Johnson & Johnson logo
Johnson & Johnson (JNJ)
Compare

Johnson & Johnson (JNJ) Yield on Cost (YOC): 2.21%

The yield on cost (YOC) for Johnson & Johnson (JNJ) is 2.21%.

JNJ Yield on Cost (YOC) Metrics

YIELD ON COST (YOC)

2.21%

Forward Yield on Cost Projections

If you buy JNJ today at the current stock price of $237.00 with a yield of 2.21% and dividends continue to grow at the historical rate (5.3% CAGR), your YOC would be:

Current Yield

2.21%

YOC in 3 Years

2.71%

YOC in 5 Years

3.11%

YOC in 10 Years

4.37%

Interactive Yield on Cost Calculator

Project custom investment returns for Johnson & Johnson (JNJ) based on your custom cost basis.

Calculator Controls
Customize parameters to project your custom Yield on Cost.
$237.00
$5.24
5.25%
15 Years

Starting Yield

2.21%

Ending YOC

4.76%

Year 15 Dividend

$11.29

Cum. Dividends Recd.

$121.27

Yield on Cost Progression Graph
Detailed Projections Ledger
Year-by-year table outlining compounding dividend returns on your purchase cost basis.
YearProjected Div. / ShareYoY Dividend HikeYield on Cost (YOC)Total Dividends Recd.
Initial$5.242.21%$0.00
Year 1$5.52+5.25%2.33%$5.52
Year 2$5.80+5.25%2.45%$11.32
Year 3$6.11+5.25%2.58%$17.43
Year 4$6.43+5.25%2.71%$23.86
Year 5$6.77+5.25%2.86%$30.63
Year 6$7.12+5.25%3.01%$37.75
Year 7$7.50+5.25%3.16%$45.25
Year 8$7.89+5.25%3.33%$53.14
Year 9$8.30+5.25%3.50%$61.44
Year 10$8.74+5.25%3.69%$70.18
Year 11$9.20+5.25%3.88%$79.38
Year 12$9.68+5.25%4.09%$89.07
Year 13$10.19+5.25%4.30%$99.26
Year 14$10.73+5.25%4.53%$109.98
Year 15$11.29+5.25%4.76%$121.27

Yield on Cost (YOC) Formula

Formula: Yield on Cost = Annual Dividend / Original Purchase Price × 100

Inputs shown in the projection:

  • Original purchase price.
  • Annual dividend per share at the starting point.
  • Assumed annual dividend growth rate.
  • Projected annual dividend divided by original purchase price.

Note: Forward projections assume dividends continue to grow at the designated growth rate. Actual dividend payments are declared by corporate boards and are subject to change.

Johnson & Johnson Yield on Cost (YOC) Formula & Definition

Yield on Cost shows the dividend yield based on your original purchase price. As dividends grow, your YOC increases even if the market yield stays the same.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Johnson & Johnson Yield on Cost (YOC) FAQ

What is the yield on cost (YOC) for Johnson & Johnson (JNJ)?
The yield on cost (YOC) for JNJ stock is 2.21%.

About Johnson & Johnson

Johnson & Johnson (JNJ) operates globally, engaging in the research, development, production, and distribution of a diverse range of healthcare products. In a pivotal strategic move in 2023, the company divested its Consumer Health division, establishing it as the independent entity Kenvue Inc. This separation was implemented to allow J&J to sharpen its focus on higher-growth, innovation-led areas. Consequently, well-known consumer brands like TYLENOL, LISTERINE, and BAND-AID are now part of Kenvue's portfolio. Johnson & Johnson's current operations are centered around two primary divisions: Innovative Medicine and MedTech. The Innovative Medicine segment, formerly known as Pharmaceuticals, specializes in prescription drugs designed to treat complex ailments such as rheumatoid arthritis, various forms of cancer, HIV/AIDS, and neurodegenerative disorders. Its MedTech division, encompassing Medical Devices, delivers cutting-edge technological solutions, including electrophysiology equipment, neurovascular care products, orthopaedic implants for hips, knees, and spine, advanced surgical technologies, and ACUVUE brand disposable contact lenses. These two streamlined segments primarily cater to a client base comprising hospitals, medical professionals, wholesale distributors, and retail outlets. From its headquarters in New Brunswick, New Jersey, Johnson & Johnson continues to uphold its enduring mission of advancing human health, a commitment it has maintained since its founding in 1886.

New Brunswick, NJ
138,100 employees
Healthcare / Drug Manufacturers - General
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Joaquin Duato